Oxalic Acid

Oxalic Acid

SCHEMBL7660429

CCCCNC(=O)[C@@H]1Cc2c(OCC)cccc2N1C(=O)[C@@H](N)CC.O=C(O)C(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.65
ALDH1A1 P00352 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP3A4 P08684 1/20 0.65
CYP2D6 P10635 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 1/20 0.44
AGTR2 P50052 1/20 0.42
PKM P14618 1/20 0.36
FKBP1A P62942 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6243831 0.97 KDM4E (0.68) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
Oxalic Acid SCHEMBL7040934 0.92 KDM4E (0.66) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL6245009 0.89 KDM4E (0.69) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
Oxalic Acid SCHEMBL7043095 0.83 KDM4E (0.60) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL6244765 0.83 KDM4E (0.51) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL6243678 0.80 KDM4E (0.63) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL6244780 0.79 KDM4E (1.00) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL5568508 0.79 KDM4E (1.00) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL29440105 0.79 KDM4E (1.00) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL7657397 0.78 KDM4E (0.67) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403561-B1 DISORDERS ASSOCIATED WITH THE INACTIVATION OR EXCESSIVE DEGRADATION OF CHOLECYSTOKININ; INHIBITING THE ENZYMATIC HYDROLYSIS OF CHOLECYSTOKININ 1-(2(S)-AMINOBUTYRYL)-2(S)-INDOLINECARBOXYLIC ACID INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-06-11 US disclosed